Medscape

Patients with advanced SSC of the anal canal have a marked survival benefit when immunotherapy is added to standard-of-care chemotherapy, su...

A data-driven analysis of a large cohort of patients with ANCA-associated vasculitis subclassified the condition into five distinct clusters...

One expert argues "yes," the other, "no." Which will prevail? Medscape Medical News

Subcutaneous injections save time, taking about 7 minutes, vs 30-60 minutes for intravenous infusion. Medscape Medical News

A study highlighted a mismatch between current lung cancer screening eligibility criteria and actual lung cancer risk. Medscape Medical N...

The decline in condom use may result from inadequate sex education and sexual awareness, as well as limited access to contraceptives, accord...

A study found that acupuncture did not provide clinically significant relief for chronic neck pain compared with fake or no treatment. Me...

Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press conference to highlight...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer. Medscape Me...

Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks. Medscape Medical News

Intermediate-stage hepatocellular carcinoma remains a challenge to treat. The new findings may lead to a new treatment strategy for these pa...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, underscore the...

The lack of a disease-free survival benefit with adjuvant durvalumab in early-stage resected non-small cell lung cancer in the CCTG BR.31 tr...

Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall or progression-f...

More than 1000 people age 12 years and older were enrolled in pivotal trials of the IL-13 inhibitor. Medscape Medical News

Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial. Medscape Medical News

Some argue universal suicide screening saves lives. Others contend it is ineffective and possibly harmful. So, what is the most effective wa...

In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they'd evolved to wit...

A new analysis sheds light on the unique challenges faced by FG medical students and the type of support they need from their institutions t...

Data from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally consistent with those observed with GLP...

A little levity may bring relief to dry eyes, according to a new study, which found laughter therapy was as effective as eye drops in improv...

Healthcare providers should adopt preventive measures for both asthma and type 2 diabetes in patients diagnosed with either condition, sugge...

The new medication was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May. Medscape Medical News

In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing the risk for dem...

In 23 states, more than one in three (35%) have obesity. Medscape Medical News